Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston
boston blog main
boston top stories
clinical trials
deals
fda
life sciences
national blog main
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
avapritinib
blueprint medicines
complement system
cstone pharmaceuticals
eli lilly
european medicines agency
fisogatinib
flatiron health
genentech
generalized myasthenia gravis
hepatocellular carcinoma
immune-mediated necrotizing myopathy
investing
jeff albers
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
ra pharmaceuticals
rare disease drugs
roche
san francisco blog main
san francisco top stories
selpercatinib
thermo fisher scientific
thyroid cancer
ucb
zilucoplan
What
candidate
2
×
drug
2
×
medicines
alternative
approval
autoimmune
blueprint
cancer
currently
deal
disease
expensive
fda
lead
marketing
muscle
pact
pharma
pharmaceuticals
potential
ra
regulatory
ret
review
roche
stakes
team
territory
ucb
viewed
wins
world
Language
unset
2
×
Current search:
drug
×
biotech
×
unset
×
candidate
×
@xconomy.com
4 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma